Adverse cutaneous reactions to psychotropic drugs
- PMID: 9314710
- DOI: 10.1016/S0033-3182(97)71418-X
Adverse cutaneous reactions to psychotropic drugs
Abstract
Psychotropic drugs are frequently used in both psychiatric and general medical practice. Familiarity with common side effects and their management may assist psychiatrists in the selection of agents to suit individual patient needs. The authors describe the morphologic features and pathologic basis of cutaneous reactions to drugs and discuss the common and reported cutaneous side effects of psychotropic drugs. Although most dermatologic reactions to drugs follow a benign course after drug discontinuation, more serious effects are known to occur with certain agents. An overview of the diagnosis and management of these adverse drug reactions is provided.
Similar articles
-
Psychiatric medications: adverse cutaneous drug reactions.Clin Dermatol. 2013 Jan-Feb;31(1):101-9. doi: 10.1016/j.clindermatol.2011.11.014. Clin Dermatol. 2013. PMID: 23245981
-
Dermatologic side effects of psychotropic medications.Psychosomatics. 2014 Jan-Feb;55(1):1-20. doi: 10.1016/j.psym.2013.07.003. Epub 2013 Oct 4. Psychosomatics. 2014. PMID: 24099686 Review.
-
Adverse cutaneous reactions to psychopharmaceuticals.Acta Dermatovenerol Croat. 2010;18(1):56-67. Acta Dermatovenerol Croat. 2010. PMID: 20361889 Review.
-
Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.J Clin Psychiatry. 2009 Sep;70(9):1258-65. doi: 10.4088/JCP.08m04563. Epub 2009 Jun 16. J Clin Psychiatry. 2009. PMID: 19538904
-
[Cutaneous side effects due to psychiatric drugs].Vertex. 2008 Nov-Dec;19(82):348-56. Vertex. 2008. PMID: 19424517 Review. Spanish.
Cited by
-
Effect of thioridazine on antioxidant status of HEMn-DP melanocytes.Naunyn Schmiedebergs Arch Pharmacol. 2015 Oct;388(10):1097-104. doi: 10.1007/s00210-015-1144-z. Epub 2015 Jun 24. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 26105001 Free PMC article.
-
Psychocutaneous disorders.Curr Psychiatry Rep. 2001 Jun;3(3):219-25. doi: 10.1007/s11920-001-0057-3. Curr Psychiatry Rep. 2001. PMID: 11353586 Review.
-
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial.BMJ Neurol Open. 2020 Jul 9;2(1):e000060. doi: 10.1136/bmjno-2020-000060. eCollection 2020. BMJ Neurol Open. 2020. PMID: 33681788 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical